Navigation Links
Nexavar Significantly Improved Overall Survival in Phase 3 Asia-Pacific Liver Cancer Trial
Date:8/26/2007

Trial to be Stopped Early to Allow All Patients Access to Nexavar

WAYNE, N.J. and EMERYVILLE, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that a planned review by an independent data monitoring committee (DMC) found that Nexavar(R) (sorafenib) tablets significantly improved overall survival, progression free survival, and time to progression in an Asia-Pacific regional Phase 3 trial of patients with advanced hepatocellular carcinoma (HCC), the most common form of liver cancer. Based on the DMC's recommendation, the trial will be stopped to allow all patients to receive treatment with Nexavar. Data from this study will be submitted for presentation at an upcoming scientific meeting.

The Asia-Pacific liver cancer study was conducted at the request of Asian health authorities in order to provide supplemental information on Nexavar's efficacy and safety in Asia-Pacific patient populations. Supplemental regulatory filings have been completed in several countries/regions including Europe, China and the United States for Nexavar in the treatment of liver cancer. These filings were based on positive data from the pivotal Phase 3 SHARP study announced earlier this year. Additional regulatory submissions for Nexavar in liver cancer are being finalized.

"Liver cancer incidence continues to rise in the Asia-Pacific region, due to the high prevalence of hepatitis B vi
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.; Onyx
Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients
2. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
3. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
4. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
5. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
7. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
8. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
11. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...Nov. 25 The FDA granted traditiona...s, a non-nucleoside reverse transcriptase inhibito...y indicated for use in treatment-experienced adult...1 strains resistant to an NNRTI and other antiretr...based on 48-week data from two Phase 3 studies kno...
(Date:11/25/2009)...lif., Nov. 25 AMPAC Fine Chemicals...ration (Nasdaq: APFC ) announced today that it re...nability Award at the Annual Statewide Environment...rs and Technology Association (CMTA), the Industri...l Industry Council of California (CICC) held in Sa...
(Date:11/25/2009)...v. 25 Reportlinker.com announces t...ts catalogue: ,, United States Dental Devices ...://www.reportlinker.com/p0158733/United-States-Den...html ,, United States Dental Devices Market An... This report is an essential source for in-depth i...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Cardica Receives NASDAQ Notification of Non Compliance 13866 1Cardica Receives NASDAQ Notification of Non Compliance 13866 2Exercise May Help Maintain Weight Loss 56302 1Exercise May Help Maintain Weight Loss 56302 2Pharmacists Urge the Public to Begin Getting Immunized 56298 1Pharmacists Urge the Public to Begin Getting Immunized 56298 2Pharmacists Urge the Public to Begin Getting Immunized 56298 3
(Date:11/26/2009)... , NEW YORK, Nov. 27 With col... ever to employ good practices to control the spre... to be proactive not only to keep ourselves health...," said Eileen Finerty, RN, MS, CIC (certified in ... control and occupational health at Hospital for S...
(Date:11/26/2009)...e copper sequestering drug tetrathiomolybdate (TM)...treatment of Wilson disease, a disease caused by a...rs. That much is known. Very little, however, is k...el. , A new study led by Northwestern University...the three-dimensional structure of TM bound to cop...
(Date:11/26/2009)... No more letters from the Nor...rsonalized text messages from Santa , ...t to increase operational efficiencies at the Nort... help keep children all over the globe informed of...es in Santa’s research department have ident...
(Date:11/26/2009)... Benton Communications announ... growth system for retailers struggling to make an...WEB) November 26, 2009 -- Flu fears is the type of... the emergency room, according to Dr. David Benton...eleased business growth system – The Rfacto...
(Date:11/25/2009)... , KANSAS CITY, Mo., Nov. 25 ...y become the nation,s largest medical clinic on De...ries of massive free clinics for uninsured people....o be the biggest one yet, because it will extend o...ekdays instead of over a weekend," Sheri Wood, exe...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2
...nfectious Diseases says that cholesterol-lowering ...he event of an influenza pandemic. They are also r...terol levels in the blood by blocking the liver's ...t these effects also help patients with serious in...
...o the strike against OBC reservation in educationa...today said that not paying salary // to doctors fo... is not a punitive action. No work, no pay. If cou...alaries despite the Supreme Court assurance that n...
... with UN to initiate a programme for creating awar...f NCC M C Bhandari said today. // Awareness ...here were medicines for their treatment and people...lso be signed, he added. Besides, an agreemen...
...black adults scored the best in hearing abilities ...e nation//. And Non-Hispanic women were found to b...lliam Murphy, Christa Themann, and Mark Stephenson...s aged 20-69 who were asked to identify themselves...
...major surgery of all inflammatory bowel diseases (...ty risks// in women, which was concluded from anal...dies. Infertility was defined as a failure to..., producing severe diarrhoea and rectal bleeding. ...
...aled that variants of a sugar, is found to improve...s are still in ithe nascent stages, these findings...Alzheimers and even offset the onslaught. A ... A treatment based on this, Scyllo-inositol treatm...
Other Medicine News:Health News:Statins Could Play Important Role In Influenza Pandemic 2Health News:U.S: Prize for the best hearing category (ethnic groups) goes to…. Non-Hispanic Blacks 2
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: